These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30530893)

  • 21. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.
    Šimić G; Španić E; Langer Horvat L; Hof PR
    Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood-brain barrier and Alzheimer's disease].
    Kuwahara H; Nishida Y; Yokota T
    Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
    Laurent C; Buée L; Blum D
    Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
    Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
    Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
    Avila J; Lim F; Moreno F; Belmonte C; Cuello AC
    Mol Neurobiol; 2002 Jun; 25(3):213-31. PubMed ID: 12109872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Huang W; Xia Q; Zheng F; Zhao X; Ge F; Xiao J; Liu Z; Shen Y; Ye K; Wang D; Li Y
    J Alzheimers Dis; 2023; 94(s1):S335-S354. PubMed ID: 36683511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of the blood-brain barrier in Alzheimer's disease].
    Gosselet F; Candela P; Cecchelli R; Fenart L
    Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alzheimer's disease: new prospects in therapy and applied experimental models].
    Kubis AM; Janusz M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysfunction of the neurovascular unit in diabetes-related neurodegeneration.
    Yan C; Zhou Y; Chen Q; Luo Y; Zhang JH; Huang H; Shao A
    Biomed Pharmacother; 2020 Nov; 131():110656. PubMed ID: 32841897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
    Provias J; Jeynes B
    Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxysterols and the NeuroVascular Unit (NVU): A far true love with bright and dark sides.
    Saint-Pol J; Gosselet F
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105368. PubMed ID: 31026511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.
    McInerney MP; Short JL; Nicolazzo JA
    AAPS J; 2017 Jul; 19(4):940-956. PubMed ID: 28462473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.